Judging from the valuation of Changhua Pharmaceutical by the outside world, Zheng Yan's current conditions can be regarded as a premium acquisition.

With such conditions, it can even be said that the premium is almost doubled, so Zheng Yan is so confident that Su Zhe will definitely agree.

In fact, with the relationship between Zheng Yan and Su Zhe, although he wants to acquire Changhua Pharmaceutical, he will not want to exchange shares for shares.

But there is no way now, this is the unanimous decision of the senior management of Zheng's Pharmaceutical Group, they all think that Changhua Pharmaceutical can develop so quickly, it is definitely related to Su Zhe, it is because of him that Changhua Pharmaceutical came back to life, including Zheng Yan, also thinks so.

If there is no Su Zhe, maybe Changhua Pharmaceutical will have no advantage, and even if Zheng's Pharmaceutical Group acquires Changhua Pharmaceutical, it is estimated that there will be no future for development.

However, Changhua Pharmaceutical, which has great development potential, is something that Zheng does not want to give up.

Therefore, the meaning of the group's top management is to adopt the method of exchanging shares for shares, and want Changhua Pharmaceutical to merge into the Zheng Group, and then slowly assimilate Changhua Pharmaceutical.

After getting the method of Changhua Pharmaceutical's rapid development from Su Zhe, he will find a way to kick him out of the Zheng Group.

For these capitalists, they all think that it is very easy to get back the shares owned by Su Zhe, so they are not worried about anything.

And although Zheng Yan was very dissatisfied with Su Zhe and wanted to kill him as soon as possible, he also knew that this plan was the greatest benefit to Zheng's Pharmaceutical Group.

Now Zheng's Pharmaceutical Group. It is very necessary for Changhua Pharmaceutical to join, so that it can occupy a place in the pharmaceutical industry.

For a family like the Zheng family. Maximizing interests is the most important thing, and in the case that the other party has use value, personal grievances can be put aside first and not taken care of for the time being.

That's why Zheng Yan found Su Zhe today and proposed to him a plan to exchange shares for shares.

"No, I don't have any plans to sell my shares right now."

Just when Zheng Yan was full of hope, thinking that Su Zhe would agree. Su Zhe directly refused.

Although this condition seemed very tempting and human, Su Zhe still refused without hesitation. Because he never thought that he would sell his shares in Changhua Pharmaceutical.

Hearing Su Zhe's answer, Zheng Yan's originally confident smile suddenly froze on his face.

He believes that this condition is already very high, although the development potential of Changhua Pharmaceutical is very large. There are many people who want to buy shares in Changhua Pharmaceutical.

But even so, Zheng Yan is still confident that this condition is already the highest, and no one will be higher than this condition.

But Zheng Yan never thought that Su Zhe would refuse very simply now, and without even taking a moment to think about it, he directly refused, without even the slightest hesitation.

"Su Zhe, didn't you hear the conditions I opened clearly. Or if you are not satisfied with this condition, then we can continue to discuss. "Zheng Yan is a little out of proportion now, and he is not as polite as he was to Su Zhe before. It's already called by name.

Because such a result was something Zheng Yan had never expected, it was beyond his expectations.

He originally thought that Su Zhe had the most, and he was only trying to raise this condition a little, and he had already thought about how to deal with it, even if Su Zhe's request was not too much. He won't refuse.

Because as long as you get the shares of Changhua Pharmaceutical, the Zheng family will be in charge. At that time, it will not be Su Zhe's turn to make a decision.

And when Su Zhe has no use value, the Zheng family can also use some means to take back these things, so that Su Zhe has nothing, so even if Zheng Yan is asked to make concessions to Su Zhe now, he can agree.

But he didn't expect Su Zhe to refuse directly, which was the most unexpected result for Zheng Yan.

"No, it's that I don't want to sell my shares." Su Zhe refused again.

Although Zheng Yan's current conditions, in the eyes of the outside world, it can be regarded as a premium acquisition

Because with the outside world's current valuation of Changhua Pharmaceutical, 60% of Su Zhe's shares are only worth 3 billion US dollars.

And now Zheng Yankai's conditions are already worth at least 5.8 billion US dollars, and when Zheng develops a new drug, it may be worth more than 8 billion US dollars.

So in this way, this condition has far exceeded the value of 60% of the shares of Changhua Pharmaceutical.

However, this is only the outside world's understanding of Changhua Pharmaceutical, which is not thorough enough, and has not seen the true value of Changhua Pharmaceutical, so it is only valued at 5 billion US dollars, and this valuation only includes the fixed assets of Changhua Pharmaceutical, and does not include drugs such as thawing spirit.

Because Changhua Pharmaceutical has never announced its revenue, no outsiders can know Changhua Pharmaceutical's profits.

With Su Zhe's cheat, Changhua Pharmaceutical does not need to invest high R&D expenses like other pharmaceutical companies, so Changhua Pharmaceutical's net profit is very impressive, which is unimaginable to outsiders.

Changhua Pharmaceutical Co., Ltd. now sells more than 5 million tablets of each drug per day in the domestic market alone, and the net profit in the domestic market is more than 22 million a day.

The daily sales volume of each drug in the foreign market is about 6 million tablets, because the price of Changhua Pharmaceutical in the foreign market is higher, and the net profit has increased several times, and the net profit brought by the foreign market to Changhua Pharmaceutical is more than 120 million a day.

Changhua Pharmaceutical's domestic and foreign markets have a net profit of more than 140 million a day.

It is 140 million a day, and Changhua Pharmaceutical's net profit in the next year will be more than 50 billion, even if it is converted into US dollars, it will be more than 8.3 billion.

Changhua Pharmaceutical's net profit in the next year will be more than $8.3 billion, if those evaluation agencies know, may only give Changhua Pharmaceutical, with a valuation of $5 billion?

This is obviously impossible, and even a tenfold increase in valuation would not be too much.

In terms of Changhua Pharmaceutical's current development prospects, as well as operating income and net profit, a valuation of at least $50 billion is reasonable, and it is the lack of information from the outside world that will give a valuation of $5 billion.

In other words, the current value of Changhua Pharmaceutical is almost more than twice as high as the current market value of Zheng's Pharmaceutical Group.

In this way, 60% of Changhua Pharmaceutical's shares are worth at least more than 30 billion US dollars, and now Zheng Yan's conditions, shares plus cash, are only 5.8 billion US dollars, such conditions are different from empty gloves white wolf.

This is obviously a loss-making business, how could Su Zhe agree, isn't this sending money to the Zheng Group for nothing?

He saw the interests in the middle very clearly, so he refused without hesitation. (To be continued)